Gonadotropin Releasing Hormone
Links shared publicly online about this topic
ingentaconnect Gonadotropin-Releasing Hormone Agonists and the Risks of Type 2 D...
ingentaconnect.com — “ingentaconnect Gonadotropin-Releasing Hormone Agonists and the Risks of Type 2 D...” View full resource at ingentaconnect.com
Most Recently Shared on February 18, 2011 at 1:23 am By:
Gonadotropin-Releasing Hormone Agonists and the Risks of Type 2 Diabetes and Cardiovascular Disease in Men with ... http://bit.ly/eawuXu
Neurology Medical News about Gonadotropin-Releasing Hormone
mdlinx.com — “Minireview: Kisspeptin/Neurokinin B/Dynorphin (KNDy) Cells of the Arcuate Nucleus: A Central Node in the Control of Gonadotropin-Releasing Hormone Secretion” View full resource at mdlinx.com
Most Recently Shared on June 9, 2010 at 7:44 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Minireview: Kisspeptin/Neurokinin B/Dynorphin (KNDy) Cells of the Arcuate Nucleus: A Central Nod... http://bit.ly/brge3h #neurology #mdlinx
Neurology Medical News about Gonadotropin-Releasing Hormone
mdlinx.com — “Recent Discoveries on the Control of Gonadotrophin-Releasing Hormone Neurones in Nonhuman Primates” View full resource at mdlinx.com
Most Recently Shared on June 17, 2010 at 3:42 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Recent Discoveries on the Control of Gonadotrophin-Releasing Hormone Neurones in Nonhuman Primat... http://bit.ly/cArgN7 #neurology #mdlinx
Ob/Gyn Medical News about Gonadotropin-Releasing Hormone
mdlinx.com — “Comparison of GnRH antagonist with long GnRH agonist protocol after OCP pretreatment in PCOs patients” View full resource at mdlinx.com
Most Recently Shared on April 16, 2010 at 6:06 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Comparison of GnRH antagonist with long GnRH agonist protocol after OCP pretreatment in PCOs patients: Archive... http://bit.ly/bQGonL #OBG
Ob/Gyn Medical News about Gonadotropin-Releasing Hormone
mdlinx.com — “Pituitary sensitizing effect of GnRH antagonists: a mechanism explaining LH escape during IVF” View full resource at mdlinx.com
Most Recently Shared on April 17, 2010 at 12:45 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Pituitary sensitizing effect of GnRH antagonists: a mechanism explaining LH escape during IVF: Human Reproduction http://bit.ly/9qL1wg #OBG
Urology Article | Gonadotropin-Releasing Hormone Blockers and Cardiovascular Disease Risk: Analysis of Prospective Clinical Trials of Degarelix
mdlinx.com — “Gonadotropin-Releasing Hormone Blockers and Cardiovascular Disease Risk: Analysis of Prospective Clinical Trials of Degarelix” View full resource at mdlinx.com
Most Recently Shared on October 20, 2011 at 12:16 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Gonadotropin-Releasing Hormone Blockers and Cardiovascular Disease Risk: Analysis of Prospective Clinic... http://t.co/8hxG1COE #urology
Oncology Article | Gonadotropin-Releasing Hormone Menopause Menopause, Premature Premenopause Breast Neoplasms
mdlinx.com — “Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: A randomized trial” View full resource at mdlinx.com
Most Recently Shared on July 20, 2011 at 5:41 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-in... http://bit.ly/pr0iV4 #oncology
FDA conducting safety review of gonadotropin-releasing hormone (GnRH) agonists - ONA
oncologynurseadvisor.com — “The FDA has notified healthcare professionals and patients of a preliminary and ongoing review which suggests an increase in the risk of diabetes and certain cardiovascular diseases in men treated with gonadotropin-releasing hormone (GnRH) agonists for the treatment of prostate cancer.” View full resource at oncologynurseadvisor.com
Most Recently Shared on May 3, 2010 at 8:48 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
FDA conducting safety review of gonadotropin-releasing hormone (GnRH) agonists http://goo.gl/fb/lG64E
Effect of Zoledronic Acid on Bone Mineral Density in Men with Prostate Cancer Receiving Gonadotropin-Releasing Hormone Analog
hindawi.com — “Background. Loss of bone density with androgen deprivation therapy for prostate cancer is well recognized. We assessed the effects of quarterly infusion of zoledronic acid on bone mineral density (BMD) and markers of bone turnover over a one-year period in men receiving gonadotropin-releasing hormone analog (GnRH-a) for prostate cancer. Methods. 41 subjects were randomly assigned to treatment with zoledronic acid (4--mg) IV infusion or placebo every 3 months. The primary endpoint was the change ” View full resource at hindawi.com
Most Recently Shared on October 15, 2010 at 6:57 pm By:
Symposier Endocrino Health Site
Effect of Zoledronic Acid on Bone Mineral Density in Men with Prostate Cancer Receiving Gonadotropin-Releasing Hormone http://bit.ly/cxdZ3G
Effects of Atrazine and Its Withdrawal on Gonadotropin-Releasing Hormone Neuroendocrine Function in the Adult Female Wistar Rat " Biology of Reproduction
biolreprod.org — “Effects of Atrazine and Its Withdrawal on Gonadotropin-Releasing Hormone Neuroendocrine Function in the Adult Female Wistar Rat " Biology of Reproduction” View full resource at biolreprod.org
Most Recently Shared on August 20, 2009 at 9:01 pm By:
Atrazine acts in the brain to disrupt the hormones that trigger ovulation. EHN summary http://ow.ly/kKOu Biol Reprod http://ow.ly/kKPj
Degarelix: a gonadotropin-releasing hormone antago... [Clin Ther. 2009] - PubMed result
ncbi.nlm.nih.gov — “PubMed is a service of the U.S. National Library of Medicine that includes over 18 million citations from MEDLINE and other life science journals for biomedical articles back to the 1950s. PubMed includes links to full text articles and other related resources.” View full resource at ncbi.nlm.nih.gov
Most Recently Shared on February 19, 2010 at 9:09 am By:
prostate_cancer Health Organization
Degarelix: a gonadotropin-releasing hormone antagonist for the management of prostate cancer. - http://bit.ly/c94Lyq
Gonadotropin-releasing hormone agonists and the ri... [Drugs. 2011] - PubMed result
ncbi.nlm.nih.gov — “PubMed is a service of the U.S. National Library of Medicine that includes over 19 million citations from MEDLINE and other life science journals for biomedical articles back to the 1950s. PubMed includes links to full text articles and other related resources.” View full resource at ncbi.nlm.nih.gov
Most Recently Shared on June 5, 2011 at 8:12 pm By:
prostate_cancer Health Organization
Gonadotropin-releasing hormone agonists and the risks of type 2 diabetes and cardiovascular disease in men with... - http://1.usa.gov/jnXQJX
FDA conducting safety review of gonadotropin-releasing hormone (GnRH) agonists - MPR
empr.com — “The FDA has notified healthcare professionals and patients of a preliminary and ongoing review which suggests an increase in the risk of diabetes and certain cardiovascular diseases in men treated with gonadotropin-releasing hormone (GnRH) agonists for the treatment of prostate cancer.” View full resource at empr.com
Most Recently Shared on May 3, 2010 at 9:09 pm By:
MPR News: FDA conducting safety review of gonadotropin-releasing hormone (GnRH) agonists: The FDA has notified hea... http://bit.ly/98AHkZ
Effect of the Gonadotropin-Releasing Hormone Analogue Triptorelin on the Occurrence of Chemotherapy-Induced Early Menopause in Premenopausal Women With Breast Cancer, July 20, 2011, Del Mastro et al. 306 (3): 269 — JAMA
jama.ama-assn.org — “Effect of the Gonadotropin-Releasing Hormone Analogue Triptorelin on the Occurrence of Chemotherapy-Induced Early Menopause in Premenopausal Women With Breast Cancer, July 20, 2011, Del Mastro et al. 306 (3): 269 — JAMA” View full resource at jama.ama-assn.org
Most Recently Shared on July 20, 2011 at 4:20 pm By:
Brandon Hayes-Lattin Doctor, Internist, Oncologist, and Physician
Effect of Triptorelin on Occurrence of Chemotherapy-Induced Early Menopause in Premenopausal Women With Breast Cancer http://t.co/CVIJerX
Effect of the Gonadotropin-Releasing Hormone Analogue Triptorelin on the Occurrence of Chemotherapy-Induced Early Menopause in P remenopausal Women With Breast Cancer - OncologySTAT
oncologystat.com — “2011 Jul 20;306(3):269-276 - L Del Mastro, L Boni, A Michelotti, T Gamucci, N Olmeo, S Gori, M Giordano, O Garrone, P Pronzato, C Bighin, A Levaggi, S Giraudi, N Cresti, E Magnolfi, T Scotto, C Vecchio, M Venturini” View full resource at oncologystat.com
Most Recently Shared on July 29, 2011 at 1:02 pm By:
OncologySTAT Health Site and Oncology
Story of the Week: Triptorelin Reduces Chemotherapy-Induced Early Menopause in Breast Cancer http://t.co/7wRoZby
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Diabetes, Type 2
Organizing type 2 diabetes resources shared by health experts, advocates, and organizations into WisdomCards.
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
Advertisement
